Active Ingredient History

NOW
  • Now
Diazepam is a benzodiazepine first discovered at Hoffman-La Roche in the late 1950s. Diazepam was approved by FDA for the treatment of anxiety disorders as well as for such conditions as skeletal muscle spasm, alcohol withdrawal syndrom and convulsions (under the most known brand Valium). The drug acts by binding to GABA-A receptors and potentiating GABA evoked current. Chronic diazepam use is associated with tolerance, dependence, and withdrawal.   NCATS

  • SMILES: CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C3=CC=CC=C3
  • InChIKey: AAOVKJBEBIDNHE-UHFFFAOYSA-N
  • Mol. Mass: 284.74
  • ALogP: 3.15
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$0.0208 - $336.3064

Australia

$0.0254 - $24.7011
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

7-chloro-1,3-dihydro-1-methyl-5-phenyl-2h-1,4-benzodiazepin-2-one | alupram 10 | alupram 2 | alupram 5 | apozepam | atensine | dialar | dialar fte | diastat | diastat acudial | diazemuls | diazepam | diazepam intensol | dizac | e-pam | la-iii | methyl diazepinone | paxel | q-pam | relanium | ro-52807 | ro-5-2807 | scriptopam | serenack | solis | stesolid | tensium | tranimul | valclair | valium | valrelease | vivol | wy-3467

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue